We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies
CLGN

7 hedge funds and large institutions have $7.42M invested in CollPlant Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

18% more capital invested

Capital invested by funds: $6.28M → $7.42M (+$1.14M)

17% more funds holding

Funds holding: 6 → 7 (+1)

0.4% more ownership

Funds ownership: 0.97% → 1.38% (+0.4%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MIH
Meitav Investment House
Israel
+$1.13M
2
IMOV
Investment Management of Virginia
Virginia
+$900K
3
SDJVC
St. Denis J. Villere & Co
Louisiana
+$225K
4
Citadel Advisors
Citadel Advisors
Florida
+$98.7K
5
Renaissance Technologies
Renaissance Technologies
New York
+$900

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$3.87K

CLGN Hedge Fund Activity: Q3 2020 in Review

7 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q3 2020, worth a combined $7.42M — up 18% from $6.28M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CLGN positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Meitav Investment House, adding an estimated $1.13M. The largest seller was UBS Group, cutting an estimated $3.87K.

  • 7 institutional investors held CollPlant Biotechnologies (CLGN) as of Q3 2020, up from 6 in Q2 2020.
  • Funds reported $7.42M of CollPlant Biotechnologies stock for Q3 2020, up 18% quarter-over-quarter.
  • 1 fund opened new CollPlant Biotechnologies positions in Q3 2020 and 0 closed out, a net change of +1 holder.
  • The largest CollPlant Biotechnologies buyer in Q3 2020 was Meitav Investment House, an estimated $1.13M added.
  • The largest CollPlant Biotechnologies seller in Q3 2020 was UBS Group, an estimated $3.87K sold.

Based on aggregated 13F filings for Q3 2020.